Navigation Links
Texcel Selects Tiziani Whitmyre for Public Relations, Internet Marketing Services
Date:2/2/2009

SHARON, Mass., Feb. 2 /PRNewswire/ -- Texcel, a leading provider of custom medical device development and manufacturing solutions, has selected Tiziani Whitmyre, Inc. as its public relations and Internet marketing services partner.

Tiziani Whitmyre (www.tizinc.com), is a Boston-area interactive marketing and public relations services agency specializing in working with life science and technology-based companies to build brands, generate sales leads, and deliver an ROI which maximizes payback on marketing communications budgets.

Texcel, based in East Longmeadow, Mass., partners with companies around the globe to accelerate the commercialization of their implantable, surgical, and interventional medical device technologies. Texcel provides specialized services and/or full medical device solutions including device design, development history file maintenance, quality (QA & QC), regulatory assistance, process validation, and general manufacturing, electronic testing, laser welding, and clean-room packaging for a wide range of product applications.

Specifically, Texcel (www.texcelmedical.com) has engaged Tiziani Whitmyre to promote both their new and existing technologies and services to the medical design industry through the creation and execution of public relations programs and the design and development of web site and marketing collateral.

Tiziani Whitmyre recently launched Texcel's new StimX implantable stimulation system with a successful integrated public relations and marketing service campaign that supported the new product's introduction at a recent major medical design and manufacturing trade conference.

"Tiziani Whitmyre's launch of our new StimX system exceeded our expectations on all fronts, and we're looking forward to building upon that launch by continuing to expand our position in the medical device industry with the help of Tiziani Whitmyre in 2009," said Keith Checca, excel Director of Business Development.

About Tiziani Whitmyre

Tiziani Whitmyre (www.tizinc.com) is a Boston area-based marketing services and strategies agency that builds brands, generates sales leads, and delivers an ROI which maximizes payback on any marketing communications budget. Services include Internet marketing online (including search engine optimization, affiliate marketing, web design), public relations (PR) services, advertising, direct marketing, graphic design, and corporate branding strategy.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Robert Tiziani | https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=64952


'/>"/>
SOURCE Tiziani Whitmyre
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
2. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
3. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
4. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
5. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
6. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
7. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
8. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
9. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
10. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
11. Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... An April 24th article on Yahoo! Beauty discusses ... with the help of a weight loss surgery. The woman, declaring “I will not hate ... been left following her dramatic weight loss. Dr. Feiz & Associates notes that, while it ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to ... since it streamlines the reporting process and provides a familiar interface that does ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today ... throughout the Northeast U.S. , GlycoMark is the only clinically available blood ... provides a clinically proven one- to two-week measure of hyperglycemic excursions, often related ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage ... unmet medical needs, today announced that it will ... development program, based on its proprietary self-delivering RNAi ... (SID) 76 th Annual Meeting.  The SID ... relevant to skin health and disease through education, ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: